BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 32774148)

  • 1. Understanding the Role of Exercise in Nonalcoholic Fatty Liver Disease: ERS-Linked Molecular Pathways.
    Zou Y; Qi Z
    Mediators Inflamm; 2020; 2020():6412916. PubMed ID: 32774148
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Research progress on mechanism of exercise improving non-alcoholic fatty liver disease through regulating endoplasmic reticulum stress].
    Jiang CJ; Li JH
    Sheng Li Xue Bao; 2022 Oct; 74(5):816-826. PubMed ID: 36319104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutual interaction between endoplasmic reticulum and mitochondria in nonalcoholic fatty liver disease.
    Wang J; He W; Tsai PJ; Chen PH; Ye M; Guo J; Su Z
    Lipids Health Dis; 2020 Apr; 19(1):72. PubMed ID: 32284046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementing dietary sugar promotes endoplasmic reticulum stress-independent insulin resistance and fatty liver in goose.
    Geng T; Zhao X; Xia L; Liu L; Li F; Yang B; Wang Q; Montgomery S; Cui H; Gong D
    Biochem Biophys Res Commun; 2016 Aug; 476(4):665-669. PubMed ID: 27246737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.
    Yao Y
    Mol Med Rep; 2020 Mar; 21(3):1059-1070. PubMed ID: 32016448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
    Liu X; Chen S; Zhang L
    Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of endoplasmic reticulum stress and insulin resistance in the occurrence of goose fatty liver.
    Geng T; Xia L; Li F; Xia J; Zhang Y; Wang Q; Yang B; Montgomery S; Cui H; Gong D
    Biochem Biophys Res Commun; 2015 Sep; 465(1):83-7. PubMed ID: 26235878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endoplasmic reticulum stress in the pathogenesis of nonalcoholic fatty liver disease.
    Zhang XQ; Xu CF; Yu CH; Chen WX; Li YM
    World J Gastroenterol; 2014 Feb; 20(7):1768-76. PubMed ID: 24587654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway.
    Chen Z; Liu Y; Yang L; Liu P; Zhang Y; Wang X
    Immunol Lett; 2020 Jun; 222():40-48. PubMed ID: 32194141
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jiang-Zhi granules decrease sensitivity to low-dose CCl
    Yang L; Zhou Y; Song H; Zheng P
    BMC Complement Altern Med; 2019 Aug; 19(1):228. PubMed ID: 31438932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of SREBP-2 intracellular trafficking improves impaired autophagic flux and alleviates endoplasmic reticulum stress in NAFLD.
    Deng X; Pan X; Cheng C; Liu B; Zhang H; Zhang Y; Xu K
    Biochim Biophys Acta Mol Cell Biol Lipids; 2017 Mar; 1862(3):337-350. PubMed ID: 28011404
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alcoholic Fatty Liver Disease.
    Engin A
    Adv Exp Med Biol; 2017; 960():443-467. PubMed ID: 28585211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism.
    Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J
    Int Immunopharmacol; 2018 Dec; 65():256-267. PubMed ID: 30340105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a novel non‑alcoholic fatty liver disease model using cholesterol‑fed rabbits with reference to the potential role of endoplasmic reticulum stress.
    Wang Y; Zhang P; Su X; Yu Q; Chen Y; Guan H; Liu E; Fan J
    Mol Med Rep; 2018 Sep; 18(3):2898-2904. PubMed ID: 30015906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver disease.
    Zhang C; Chen F; Feng L; Shan Q; Zheng GH; Wang YJ; Lu J; Fan SH; Sun CH; Wu DM; Li MQ; Hu B; Wang QQ; Zhang ZF; Zheng YL
    Mol Med; 2019 Jun; 25(1):29. PubMed ID: 31215394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Different Exercise Intensities on Hepatocyte Apoptosis in HFD-Induced NAFLD in Rats: The Possible Role of Endoplasmic Reticulum Stress through the Regulation of the IRE1/JNK and eIF2
    Ruan L; Li F; Li S; Zhang M; Wang F; Lv X; Liu Q
    Oxid Med Cell Longev; 2021; 2021():6378568. PubMed ID: 33815655
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bax inhibitor-1 protects from nonalcoholic steatohepatitis by limiting inositol-requiring enzyme 1 alpha signaling in mice.
    Lebeaupin C; Vallée D; Rousseau D; Patouraux S; Bonnafous S; Adam G; Luciano F; Luci C; Anty R; Iannelli A; Marchetti S; Kroemer G; Lacas-Gervais S; Tran A; Gual P; Bailly-Maitre B
    Hepatology; 2018 Aug; 68(2):515-532. PubMed ID: 29457838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease.
    Song MJ; Malhi H
    Pharmacol Ther; 2019 Nov; 203():107401. PubMed ID: 31419516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hugan Qingzhi tablets attenuates endoplasmic reticulum stress in nonalcoholic fatty liver disease rats by regulating PERK and ATF6 pathways.
    Yang M; Yao X; Xia F; Xiang S; Tang W; Zhou B
    BMC Complement Med Ther; 2024 Jan; 24(1):36. PubMed ID: 38216941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.